Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

著者: C. Manegold, James T. Symanowski, U. Gatzemeier, Martin Reck, Joachim von Pawel, C. Kortsik, K. Nackaerts, P. Lianes, Nicholas J. Vogelzang - Annals of Oncology 2005 被引用: 163